ArticleClinical cancer research : an official journal of the American Association for Cancer Research2023

Safety and Efficacy of MEDI0457 plus Durvalumab in Patients with Human Papillomavirus-Associated Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma.

Charu Aggarwal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.